These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7536509)

  • 1. Induction of bleomycin resistance in a human oral squamous carcinoma cell line and characterisation of bleomycin-resistant and -sensitive clones.
    Urade M; Ogura T; Uematsu T; Takahashi Y; Kishimoto H; Yoshioka W
    Eur J Cancer B Oral Oncol; 1994 Nov; 30B(6):409-14. PubMed ID: 7536509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment of human squamous carcinoma cell lines highly and minimally sensitive to bleomycin and analysis of factors involved in the sensitivity.
    Urade M; Ogura T; Mima T; Matsuya T
    Cancer; 1992 May; 69(10):2589-97. PubMed ID: 1373668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peplomycin-induced apoptosis in oral squamous carcinoma cells depends on bleomycin sensitivity.
    Okamura H; Morimoto H; Haneji T
    Oral Oncol; 2001 Jun; 37(4):379-85. PubMed ID: 11337271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Combined effect of bleomycin and SDB-ethylenediamine, a synthetic isoprenoid, on oral squamous carcinoma cell lines and transplantable nude mouse tumors].
    Takahashi Y; Urade M; Kishimoto H; Arimoto T; Yanagisawa T; Yoshioka W
    Gan To Kagaku Ryoho; 1995 Jun; 22(7):883-7. PubMed ID: 7540824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of bleomycin-resistant phenotypes of human cell sublines and circumvention of bleomycin resistance by liblomycin.
    Lazo JS; Braun ID; Labaree DC; Schisselbauer JC; Meandzija B; Newman RA; Kennedy KA
    Cancer Res; 1989 Jan; 49(1):185-90. PubMed ID: 2461797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic inactivation: a mechanism of human tumor resistance to bleomycin.
    Sebti SM; Jani JP; Mistry JS; Gorelik E; Lazo JS
    Cancer Res; 1991 Jan; 51(1):227-32. PubMed ID: 1703034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment of three bleomycin-resistant human carcinoma cell lines and their cross-resistance to other antitumor agents.
    Urade M; Sugi M; Miyazaki T
    Cancer; 1988 Apr; 61(8):1501-7. PubMed ID: 2450630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High induction of poly(ADP-ribose) polymerase activity in bleomycin-resistant HeLa cells.
    Urade M; Sugi M; Mima T; Ogura T; Matsuya T
    Jpn J Cancer Res; 1989 May; 80(5):464-8. PubMed ID: 2473971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cysteine proteinase inhibitors and bleomycin-sensitive and -resistant cells.
    Morris G; Mistry JS; Jani JP; Sebti SM; Lazo JS
    Biochem Pharmacol; 1991 Jun; 41(11):1559-66. PubMed ID: 1710457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Further characterization of bleomycin-resistant HeLa cells and analysis of resistance mechanism.
    Urade M; Sugi M; Matsuya T
    Jpn J Cancer Res; 1988 Apr; 79(4):491-500. PubMed ID: 2454906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sensitivity to bleomycin of human cultured tumor cells and analysis of related factors].
    Urade M; Sugi M; Shirasuna K; Sugiyama M; Miyazaki T
    Gan To Kagaku Ryoho; 1983 Nov; 10(11):2382-8. PubMed ID: 6195972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Up-regulation of antioxidant enzymes and coenzyme Q(10) in a human oral cancer cell line with acquired bleomycin resistance.
    Yen HC; Li SH; Majima HJ; Huang YH; Chen CP; Liu CC; Tu YC; Chen CW
    Free Radic Res; 2011 Jun; 45(6):707-16. PubMed ID: 21486114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of homologous recombination by treatment with BVDU (brivudin) or by RAD51 silencing increases chromosomal damage induced by bleomycin in mismatch repair-deficient tumour cells.
    Vernole P; Muzi A; Volpi A; Dorio AS; Terrinoni A; Shah GM; Graziani G
    Mutat Res; 2009 May; 664(1-2):39-47. PubMed ID: 19428379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms affecting peplomycin sensitivity of Chinese hamster cell lines.
    Ozawa S; Tamura A; Suzuki H; Nishimura T; Tanaka N
    J Antibiot (Tokyo); 1985 Sep; 38(9):1257-65. PubMed ID: 2415503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liblomycin-mediated DNA cleavage in human head and neck squamous carcinoma cells and purified DNA.
    Wassermann K; Zwelling LA; Lown JW; Hartley JA; Nishikawa K; Lin JR; Newman RA
    Cancer Res; 1990 Mar; 50(6):1732-7. PubMed ID: 1689610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bleomycin hydrolase activity and cytotoxicity in human tumors.
    Lazo JS; Boland CJ; Schwartz PE
    Cancer Res; 1982 Oct; 42(10):4026-31. PubMed ID: 6179595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro selection and characterization of a bleomycin-resistant subline of B16 melanoma.
    Zuckerman JE; Raffin TA; Brown JM; Newman RA; Etiz BB; Sikic BI
    Cancer Res; 1986 Apr; 46(4 Pt 1):1748-53. PubMed ID: 2418953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Studies on the mechanism of drug resistance in tumor cells and a new antitumor antibiotic].
    Tanaka N
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2666-73. PubMed ID: 6210060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Murine strain differences in acute lung injury and activation of poly(ADP-ribose) polymerase by in vitro exposure of lung slices to bleomycin.
    Hoyt DG; Lazo JS
    Am J Respir Cell Mol Biol; 1992 Dec; 7(6):645-51. PubMed ID: 1280451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Labelling of bleomycin with Auger-emitter increases cytotoxicity in squamous-cell cancer cell lines.
    Jääskelä-Saari HA; Kairemo KJ; Ramsay HA; Grénman R
    Int J Radiat Biol; 1998 May; 73(5):565-70. PubMed ID: 9652815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.